SS
TBPH icon

Steve Schonfeld’s Theravance Biopharma TBPH Stock Holding History

Steve Schonfeld’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
+108,879
New +$1.8M 0.01% 1106
2026
Q1 		– Sell
-16,555
Closed -$310K – 2658
2025
Q4 		$310K Buy
+16,555
New +$275K ﹤0.01% 1571
2023
Q4 		– Sell
-57,426
Closed -$496K – 2198
2023
Q3 		$496K Buy
57,426
+39,350
+218% +$380K ﹤0.01% 1209
2023
Q2 		$187K Buy
+18,076
New +$200K ﹤0.01% 1588
2023
Q1 		– Sell
-29,160
Closed -$327K – 2638
2022
Q4 		$327K Buy
+29,160
New +$306K ﹤0.01% 1751

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Steve Schonfeld's TBPH Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 108,879 shares worth $1.85M. The stake represents 0.01% of the portfolio and ranks #1106 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in TBPH as recently as Q4 2025.

Steve Schonfeld first reported a position in TBPH in Q4 2022 and has held it in 5 quarters since. 178 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Steve Schonfeld held 108,879 shares of Theravance Biopharma worth $1.85M as of Q2 2026.
  • Theravance Biopharma was a new Steve Schonfeld position in Q2 2026.
  • Theravance Biopharma made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1106 holding.
  • Steve Schonfeld first reported a position in Theravance Biopharma in Q4 2022 and has held it in 5 quarters since.
  • 178 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.